Michael Secora Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Michael Secora is Chief Financial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.49 Million shares of RXRX, which is worth approximately $7.08 Million. The most recent transaction as insider was on Jun 13, 2024, when has been sold 39,375 shares (Class A Common Stock) at a price of $2.22 per share, resulting in proceeds of $87,412. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.49M

0% 3M change

20.85% 12M change

Total Value Held $7.08 Million

Michael Secora Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 13 2024	BUY Exercise of conversion of derivative security	$87,412 $2.22 p/Share	39,375 Added 3.03%	1,258,468 Class A Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$119,739 $10.01 p/Share	11,962 Reduced 0.97%	1,219,093 Class A Common Stock
Apr 17 2024	SELL Open market or private sale	$175,279 $7.58 p/Share	23,124 Reduced 1.84%	1,231,055 Class A Common Stock
Apr 17 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 2.9%	1,254,179 Class A Common Stock
Apr 16 2024	SELL Open market or private sale	$191,750 $7.67 p/Share	25,000 Reduced 2.01%	1,216,679 Class A Common Stock
Apr 16 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 2.93%	1,241,679 Class A Common Stock
Mar 13 2024	SELL Open market or private sale	$275,750 $11.03 p/Share	25,000 Reduced 2.03%	1,204,179 Class A Common Stock
Mar 13 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 2.96%	1,229,179 Class A Common Stock
Mar 12 2024	SELL Open market or private sale	$261,500 $10.46 p/Share	25,000 Reduced 2.05%	1,191,679 Class A Common Stock
Mar 12 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 2.99%	1,216,679 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$89,147 $12.43 p/Share	7,172 Reduced 0.6%	1,179,179 Class A Common Stock
Feb 14 2024	SELL Open market or private sale	$267,750 $10.71 p/Share	25,000 Reduced 2.06%	1,186,351 Class A Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.0%	1,211,351 Class A Common Stock
Feb 13 2024	SELL Open market or private sale	$246,500 $9.86 p/Share	25,000 Reduced 2.09%	1,173,851 Class A Common Stock
Feb 13 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.03%	1,198,851 Class A Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$25,346 $10.09 p/Share	2,512 Reduced 0.22%	1,161,351 Class A Common Stock
Feb 09 2024	BUY Grant, award, or other acquisition	-	182,849 Added 13.58%	1,163,863 Class A Common Stock
Jan 17 2024	SELL Open market or private sale	$256,250 $10.25 p/Share	25,000 Reduced 2.49%	981,014 Class A Common Stock
Jan 17 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.59%	1,006,014 Class A Common Stock
Jan 16 2024	SELL Open market or private sale	$261,249 $10.45 p/Share	25,000 Reduced 2.52%	968,514 Class A Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.64%	993,514 Class A Common Stock
Dec 13 2023	SELL Open market or private sale	$189,750 $7.59 p/Share	25,000 Reduced 2.55%	956,014 Class A Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.68%	981,014 Class A Common Stock
Dec 12 2023	SELL Open market or private sale	$184,750 $7.39 p/Share	25,000 Reduced 2.58%	943,514 Class A Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.73%	968,514 Class A Common Stock

Michael Secora

Chief Financial Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account